Magnus Adriansson
- Hematology top 2%
- Oncology
- Molecular Biology
- Genetics top 10%
- Biochemistry top 10%
- Co-authors
- Fredrik CelsingGunnar JuliussonIngemar TuressonClaes MalmStig LenhoffEeva JuvonenGiovanni MartinelliJesús F. San Miguel
- Topics
- Multiple Myeloma Research and Treatments (3 papers)Cancer Treatment and Pharmacology (3 papers)Cancer therapeutics and mechanisms (1 paper)
- Cited by
- HematologyBiochemistryGenetics
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Magnus Adriansson
7 papers receiving 491 citations
Peers
Comparison fields: 5 of 60
- Hematology 446
- Oncology 185
- Molecular Biology 172
- Genetics 92
- Biochemistry 75
Countries citing papers authored by Magnus Adriansson
This map shows the geographic impact of Magnus Adriansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Adriansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Adriansson more than expected).
Fields of papers citing papers by Magnus Adriansson
This network shows the impact of papers produced by Magnus Adriansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Adriansson. The network helps show where Magnus Adriansson may publish in the future.
Co-authorship network of co-authors of Magnus Adriansson
This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Adriansson. A scholar is included among the top collaborators of Magnus Adriansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Adriansson. Magnus Adriansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 267 | |
| 2 | 24 | |
| 3 | 5 | |
| 4 | 203 | |
| 5 | 2 | |
| 6 | Thalidomide frequently induces good partial remission and best response ever in patients with advanced myeloma and prior high dose melphalan and autotransplant. | 6 |
| 7 | [Treatment with enalapril causing leukopenia with septicemia and affected liver]. | 1 |
About Magnus Adriansson
Magnus Adriansson is a scholar working on Hematology, Oncology and Emergency Medicine, having authored 7 papers that have together received 508 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Hematology (446 citations), Biochemistry (75 citations) and Genetics (92 citations). Magnus Adriansson has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Fredrik Celsing, Gunnar Juliusson, Ingemar Turesson, Claes Malm, Stig Lenhoff, Eeva Juvonen, Giovanni Martinelli, Jesús F. San Miguel, Albert Altés and Martin R. Schipperus. Their work appears in journals such as Blood, British Journal of Haematology and Scandinavian Journal of Work Environment & Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.